Identification of Novel Antibacterials Using Machine Learning Techniques
Yan A. Ivanenkov, Alex A. Zhavoronkov, Renat S. Yamidanov, Ilya А. Osterman, Сергиев Петр Владимирович, Vladimir Aladinskiy, Anastasia V. Aladinskaya, Victor A. Terentiev et al.
Frontiers in Pharmacology·2019·article·cited by 47
importance 8/10ai assistedComputational Drug Discovery Methodsantibiotic discoverystage: research
Problem
Pharmaceutical companies avoid developing novel antibacterials despite urgent need for new antibiotics against resistant bacterial strains.
Why it matters
The abstract states there is an urgent need for novel antibiotics, especially against resistant bacterial strains.
What the AI did
Six in silico machine learning techniques were applied to a dataset of over 140,000 molecules with antibacterial activity against Escherichia coli to score novel molecules by antibacterial potency.
Results
not stated in source
Impact
A model was built on a large proprietary dataset, but the abstract is cut off before validation outcomes are given.
Record
Venue
Frontiers in Pharmacology
Published
2019
Work type
article
Authors
Yan A. Ivanenkov, Alex A. Zhavoronkov, Renat S. Yamidanov, Ilya А. Osterman, Сергиев Петр Владимирович, Vladimir Aladinskiy, Anastasia V. Aladinskaya, Victor A. Terentiev et al.